Tag: Intercept Pharmaceuticals
January 29, 2020
Intercept Completes Phase 3 Enrollment of Cirrhosis Treatment
Intercept has completed patient enrollment in its Phase 3 study evaluating obeticholic acid for the treatment of cirrhosis due to...
January 2, 2020
Biotech Outlook 2020: Washington Scrutiny Looms Over Sector
INN offers a closer look at the path ahead for biotech investors in 2020 as new challenges arise for the...
October 16, 2019